Published in Arthritis Rheum on March 01, 1980
The use of laboratory tests in the diagnosis of SLE. J Clin Pathol (2000) 1.92
Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med (1981) 1.74
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum (2010) 1.67
Complement and systemic lupus erythematosus. Arthritis Res (2002) 1.58
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol (1983) 1.06
Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders. Clin Exp Immunol (1981) 0.92
C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol (1987) 0.91
Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy. Arch Dermatol Res (1982) 0.88
Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J Clin Invest (1985) 0.87
C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus. Clin Exp Immunol (1990) 0.86
Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1998) 0.83
Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 0.81
Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody. Clin Exp Immunol (1991) 0.80
Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside. Rheum Dis Clin North Am (2010) 0.78
Neutrophil function in systemic lupus erythematosus and other collagen diseases. Ann Rheum Dis (1982) 0.78
Impaired response of neutrophils to a lymphokine by sera from patients with connective tissue disease. Infect Immun (1983) 0.78
Variation in circulating immune complex levels with diet, exercise, and sleep: a comparison between normal controls and patients with systemic lupus erythematosus. Ann Rheum Dis (1981) 0.75
Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes. J Clin Microbiol (1982) 0.75
Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay. Arch Dermatol Res (1985) 0.75
Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes. Clin Exp Immunol (1983) 0.75
Classifying lupus. Br Med J (Clin Res Ed) (1983) 0.75
Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis. PLoS One (2017) 0.75
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest (1994) 2.81
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med (1974) 2.20
Nehprotic syndrome with glomerular mesangial IgM deposits. Lab Invest (1978) 2.19
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
Acute interstitial nephritis due to methicillin. Am J Med (1978) 2.11
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest (1995) 1.79
Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int (2007) 1.76
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int (1999) 1.76
Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int (1994) 1.70
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J Clin Invest (1978) 1.53
Advanced achievement in internal medicine: the end of the line for voluntary recertification. J Gen Intern Med (1990) 1.52
Determinants of glomerular filtration in experimental glomerulonephritis in the rat. J Clin Invest (1975) 1.42
Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.40
Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes. Kidney Int (1977) 1.32
Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int (1992) 1.32
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest (1976) 1.27
Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis Rheum (1994) 1.26
IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med (1979) 1.22
Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int (1992) 1.21
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Evaluation of homologous and isologous passive Heymann nephritis: influence on endogenous antibody production. J Immunol (1983) 1.20
Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest (1993) 1.18
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int (1998) 1.18
Ultrasonographic demonstration of popliteal cysts in rheumatoid arthritis. A noninvasive technique. Arthritis Rheum (1976) 1.16
Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran. J Clin Invest (1976) 1.15
Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1978) 1.13
The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum (1993) 1.11
Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am J Physiol (1996) 1.10
Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum (1974) 1.07
Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA. Proc Natl Acad Sci U S A (2001) 1.06
Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol (2001) 1.06
Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int (1998) 1.06
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int (1990) 1.05
Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect. Clin Immunol Immunopathol (1981) 1.04
Pathogenesis of membranous nephropathy. Annu Rev Med (1988) 1.04
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med (1978) 1.03
Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis. J Clin Microbiol (1997) 1.02
Renal damage with intestinal bypass. Ann Intern Med (1978) 1.02
Control of proximal tubule fluid reabsorption in experimental glomerulonephritis. J Clin Invest (1975) 1.02
Integrins. Kidney Int Suppl (1994) 1.02
Elevation in urinary and blood histamine following clinical renal transplantation. Ann Surg (1971) 1.01
Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int (1997) 1.01
In vivo interactions of TGF-beta and extracellular matrix. Prog Growth Factor Res (1992) 1.00
Antigenic changes as a determinant of immune complex localization in the rat glomerulus. Lab Invest (1981) 1.00
Inhibition of macrophage migration: a test system using human monocytes. J Immunol (1971) 0.99
Failure of heparin to affect two types of experimental glomerulonephritis in rabbits. Kidney Int (1975) 0.99
Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int (1999) 0.99
Immunologic responses in patients with lepromatous leprosy. Arch Dermatol (1976) 0.98
Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol (1995) 0.98
Circulating immune complexes in rats with autologous immune complex nephritis. Lab Invest (1980) 0.98
Unimpaired B-cell function and T-cell regulation of immunoglobulin synthesis in patients with chronic hepatitis B virus infection. Clin Immunol Immunopathol (1982) 0.98
Cytokines and L-arginine in renal injury and repair. Am J Physiol (1994) 0.96
Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis. Proc Natl Acad Sci U S A (1991) 0.96
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol (1997) 0.96
Immune complex detection in glomerular diseases. Nephron (1979) 0.95
Evaluation of sequential glomerular eluates from rats with Heymann nephritis. J Immunol (1986) 0.95
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol (1995) 0.95
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95
Sternoarticular septic arthritis in heroin users. N Engl J Med (1973) 0.95
Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats. J Immunol (1984) 0.95
What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial (2000) 0.95
Gram-negative bacillary septic arthritis: clinical, radiographic, therapeutic, and prognostic features. Semin Arthritis Rheum (1977) 0.95
Fibrosis linked to TGF-beta in yet another disease. J Clin Invest (1995) 0.95
Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol (1985) 0.94
Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int (1992) 0.93
Effect of iron on acute pyelonephritis and later chronic changes. Kidney Int (1982) 0.92
Absence of glomerular renal tubular epithelial antigen in membranous glomerulonephritis. Clin Nephrol (1976) 0.92
Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med (1989) 0.92
Transforming growth factor-beta in human glomerular injury. Curr Opin Nephrol Hypertens (1997) 0.91
Goodpasture syndrome treated with immunosuppression and plasma exchange. Arch Intern Med (1977) 0.91
Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol (1980) 0.91
Extracellular matrix/growth factor interactions. Cold Spring Harb Symp Quant Biol (1992) 0.91
Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91
Human lymphocyte subpopulations. Study of T and B cells and their density distribution. Clin Immunol Immunopathol (1974) 0.90
Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans. Arthritis Rheum (1989) 0.90